Argenx Se (ARGX) Interest Expenses (2019 - 2022)
Argenx Se (ARGX) posted Interest Expenses of $448000.0 for Q2 2022, up 147.01% on a QoQ basis from -$953000.0 in Q1 2022, and down 41.36% year-over-year from $764000.0 in Q2 2021.
Argenx Se (ARGX) Interest Expenses (2019 - 2022) Analysis & Trends
Argenx Se's Interest Expenses history runs 3 years deep, the most recent figure standing at $448000.0 for Q2 2022.
- Quarterly Interest Expenses fell 41.36% year-over-year to $448000.0 in Q2 2022, while the trailing twelve-month figure through Mar 2023 was $448000.0 (up 337.04% YoY) and the FY2025 annual result came in at $4.1 million, up 65.67% from the prior year.
- Interest Expenses was $448000.0 for Q2 2022 at Argenx Se, up from -$953000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $764000.0 in Q2 2021 and bottomed at -$1.2 million in Q1 2021.
- A 3-year average of -$122657.4 and a median of $94527.9 in 2019 frame the typical range for Interest Expenses.
- Peak annual rise in Interest Expenses reached 19.51% in 2022, while the deepest fall reached 41.36% in 2022.
- Argenx Se's Interest Expenses stood at $231339.5 in 2019, then soared by 230.25% to $764000.0 in 2021, then sank by 41.36% to $448000.0 in 2022.
- Business Quant data shows ARGX's Interest Expenses at $448000.0 in Q2 2022, -$953000.0 in Q1 2022, and $764000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 69.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 448,000.00 |
| Jun 30, 2022 | 448,000.00 |
| Mar 31, 2022 | -953,000.00 |
| Mar 31, 2022 | -953,000.00 |
| Jun 30, 2021 | 764,000.00 |
| Jun 30, 2021 | 764,000.00 |
| Mar 31, 2021 | -1.18 Mn |
| Mar 31, 2021 | -1.18 Mn |
| Dec 31, 2019 | 231,339.52 |
| Dec 31, 2019 | 231,339.52 |
| Sep 30, 2019 | -42,283.74 |
| Sep 30, 2019 | -42,283.74 |